advertisement

---

Williams PA 5

Showing records 1 to 5 | Display all abstracts from Williams PA

96133 Nicotinamide and Pyruvate for Neuroenhancement in Open-Angle Glaucoma: A Phase 2 Randomized Clinical Trial
De Moraes CG
JAMA ophthalmology 2022; 140: 11-18

---

96065 Comparison of Glaucoma-Relevant Transcriptomic Datasets Identifies Novel Drug Targets for Retinal Ganglion Cell Neuroprotection
Enz TJ; Tribble JR
Journal of clinical medicine 2021; 10:

---

96133 Nicotinamide and Pyruvate for Neuroenhancement in Open-Angle Glaucoma: A Phase 2 Randomized Clinical Trial
John SWM
JAMA ophthalmology 2022; 140: 11-18

---

96065 Comparison of Glaucoma-Relevant Transcriptomic Datasets Identifies Novel Drug Targets for Retinal Ganglion Cell Neuroprotection
Williams PA
Journal of clinical medicine 2021; 10:

---

96133 Nicotinamide and Pyruvate for Neuroenhancement in Open-Angle Glaucoma: A Phase 2 Randomized Clinical Trial
Williams PA; Blumberg DM; Cioffi GA; Liebmann JM
JAMA ophthalmology 2022; 140: 11-18

---